Considering the challenges being faced by pharmacies and involvement of their workforce in the ongoing Covid-19 vaccination programme, the requirement to report New Medicine Service (NMS) data for Quarters 3 and 4 of 2021/22 has been paused.
This follows an agreement reached between the NHS England and NHS Improvement and Pharmaceutical Services Negotiating Committee (PSNC).